{
  "solution_stats": {
    "total_solutions": 3,
    "details": [
      {
        "solution_id": 1,
        "steps_count": 4
      },
      {
        "solution_id": 2,
        "steps_count": 6
      },
      {
        "solution_id": 3,
        "steps_count": 4
      }
    ]
  },
  "solutions": [
    {
      "id": 1,
      "family_id": 1,
      "path_type": "core",
      "branch_from": null,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "MT",
          "premises_used": [
            {
              "id": "Rule10",
              "prover9": "(-(A4 | -A3) -> A5)",
              "prover9_expression": "(-(approved_for_research(drug) | -requires_clinical_trials(drug)) -> banned_substance(drug))",
              "natural": "Provided that it is not the case that the drug is approved for research or exempt from clinical trials, then the drug is a banned substance."
            },
            {
              "id": "Fact4",
              "prover9": "-A5",
              "prover9_expression": "-banned_substance(drug)",
              "natural": "A drug is not a banned substance."
            }
          ],
          "conclusion": "(A4 | -A3)",
          "natural": "Either a drug is approved for research or it does not require clinical trials."
        },
        {
          "step_number": 2,
          "rule_applied": "DS",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(A4 | -A3)",
              "prover9_expression": "(approved_for_research(drug) | -requires_clinical_trials(drug))",
              "natural": "Either a drug is approved for research or it does not require clinical trials."
            },
            {
              "id": "Fact3",
              "prover9": "-A4",
              "prover9_expression": "-approved_for_research(drug)",
              "natural": "A drug is not approved for research."
            }
          ],
          "conclusion": "-A3",
          "natural": "A drug does not require clinical trials."
        },
        {
          "step_number": 3,
          "rule_applied": "MT",
          "premises_used": [
            {
              "id": "Rule9",
              "prover9": "(-(A2 -> G) -> A3)",
              "prover9_expression": "(-(approved(substance, platform) -> market_available(product)) -> requires_clinical_trials(drug))",
              "natural": "Whenever the approval of substance for the platform does not lead to market availability, the drug requires clinical trials."
            },
            {
              "id": "Derived",
              "prover9": "-A3",
              "prover9_expression": "-requires_clinical_trials(drug)",
              "natural": "A drug does not require clinical trials."
            }
          ],
          "conclusion": "(A2 -> G)",
          "natural": "If substance is approved for the platform, then the product is market available."
        },
        {
          "step_number": 4,
          "rule_applied": "DE",
          "premises_used": [
            {
              "id": "Rule2",
              "prover9": "(A1 | A2)",
              "prover9_expression": "(approved(alcohol, platform) | approved(substance, platform))",
              "natural": "Either alcohol is approved for the platform or substance is approved for the platform."
            },
            {
              "id": "Rule1",
              "prover9": "(A1 -> G)",
              "prover9_expression": "(approved(alcohol, platform) -> market_available(product))",
              "natural": "Provided that alcohol is approved for the platform, then the product becomes market available."
            },
            {
              "id": "Derived",
              "prover9": "(A2 -> G)",
              "prover9_expression": "(approved(substance, platform) -> market_available(product))",
              "natural": "If substance is approved for the platform, then the product is market available."
            }
          ],
          "conclusion": "G",
          "natural": "A product is market available."
        }
      ]
    },
    {
      "id": 2,
      "family_id": 2,
      "path_type": "core",
      "branch_from": null,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "RAA",
          "premises_used": [
            {
              "id": "Rule11",
              "prover9": "(-(-(A10 -> (A8 | (A7 -> -A6))) -> A11) -> A12)",
              "prover9_expression": "(-(-(submitted_application(substance) -> (fast_track_approval(drug) | (therapeutic_benefit(drug) -> -addictive_property(substance)))) -> application_rejected(substance)) -> appeal_filed(substance))",
              "natural": "If the failure of the implication that substance's application submission leads to fast-track approval or non-addictive therapeutic benefit does not result in application rejection, then an appeal is filed for substance."
            },
            {
              "id": "Rule12",
              "prover9": "(-(-(A10 -> (A8 | (A7 -> -A6))) -> A11) -> -A12)",
              "prover9_expression": "(-(-(submitted_application(substance) -> (fast_track_approval(drug) | (therapeutic_benefit(drug) -> -addictive_property(substance)))) -> application_rejected(substance)) -> -appeal_filed(substance))",
              "natural": "Under the condition that the non-implication of substance's application submission to approval paths not causing rejection, an appeal is not filed for substance."
            }
          ],
          "conclusion": "(-(A10 -> (A8 | (A7 -> -A6))) -> A11)",
          "natural": "Should it not be the case that submitting an application for substance implies either fast-track approval or therapeutic benefit without addictive property, then the application for substance is rejected."
        },
        {
          "step_number": 2,
          "rule_applied": "MT",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(-(A10 -> (A8 | (A7 -> -A6))) -> A11)",
              "prover9_expression": "(-(submitted_application(substance) -> (fast_track_approval(drug) | (therapeutic_benefit(drug) -> -addictive_property(substance)))) -> application_rejected(substance))",
              "natural": "Should it not be the case that submitting an application for substance implies either fast-track approval or therapeutic benefit without addictive property, then the application for substance is rejected."
            },
            {
              "id": "Fact2",
              "prover9": "-A11",
              "prover9_expression": "-application_rejected(substance)",
              "natural": "It is not the case that the application for substance is rejected."
            }
          ],
          "conclusion": "(A10 -> (A8 | (A7 -> -A6)))",
          "natural": "Whenever an application for substance is submitted, either the drug qualifies for fast-track approval or, if the drug has therapeutic benefit, then substance lacks an addictive property."
        },
        {
          "step_number": 3,
          "rule_applied": "DE",
          "premises_used": [
            {
              "id": "Rule6",
              "prover9": "(A9 | A10)",
              "prover9_expression": "(submitted_application(alcohol) | submitted_application(substance))",
              "natural": "An application has been submitted for alcohol or one has been submitted for substance."
            },
            {
              "id": "Rule5",
              "prover9": "(A9 -> (A8 | (A7 -> -A6)))",
              "prover9_expression": "(submitted_application(alcohol) -> (fast_track_approval(drug) | (therapeutic_benefit(drug) -> -addictive_property(substance))))",
              "natural": "When an application for alcohol is submitted, the outcome is either fast-track approval for the drug or, assuming therapeutic benefit, absence of addictive property in substance."
            },
            {
              "id": "Derived",
              "prover9": "(A10 -> (A8 | (A7 -> -A6)))",
              "prover9_expression": "(submitted_application(substance) -> (fast_track_approval(drug) | (therapeutic_benefit(drug) -> -addictive_property(substance))))",
              "natural": "Whenever an application for substance is submitted, either the drug qualifies for fast-track approval or, if the drug has therapeutic benefit, then substance lacks an addictive property."
            }
          ],
          "conclusion": "(A8 | (A7 -> -A6))",
          "natural": "The drug qualifies for fast-track approval, or, provided the drug has therapeutic benefit, substance has no addictive property."
        },
        {
          "step_number": 4,
          "rule_applied": "DS",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(A8 | (A7 -> -A6))",
              "prover9_expression": "(fast_track_approval(drug) | (therapeutic_benefit(drug) -> -addictive_property(substance)))",
              "natural": "The drug qualifies for fast-track approval, or, provided the drug has therapeutic benefit, substance has no addictive property."
            },
            {
              "id": "Fact5",
              "prover9": "-A8",
              "prover9_expression": "-fast_track_approval(drug)",
              "natural": "A drug does not qualify for fast-track approval."
            }
          ],
          "conclusion": "(A7 -> -A6)",
          "natural": "In the event that a drug has therapeutic benefit, substance does not possess an addictive property."
        },
        {
          "step_number": 5,
          "rule_applied": "MP",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(A7 -> -A6)",
              "prover9_expression": "(therapeutic_benefit(drug) -> -addictive_property(substance))",
              "natural": "In the event that a drug has therapeutic benefit, substance does not possess an addictive property."
            },
            {
              "id": "Fact1",
              "prover9": "A7",
              "prover9_expression": "therapeutic_benefit(drug)",
              "natural": "A drug has therapeutic benefit."
            }
          ],
          "conclusion": "-A6",
          "natural": "Substance does not have an addictive property."
        },
        {
          "step_number": 6,
          "rule_applied": "MT",
          "premises_used": [
            {
              "id": "Rule13",
              "prover9": "(-G -> A6)",
              "prover9_expression": "(-market_available(product) -> addictive_property(substance))",
              "natural": "In the event the product is not market available, substance has an addictive property."
            },
            {
              "id": "Derived",
              "prover9": "-A6",
              "prover9_expression": "-addictive_property(substance)",
              "natural": "Substance does not have an addictive property."
            }
          ],
          "conclusion": "G",
          "natural": "A product is market available."
        }
      ]
    },
    {
      "id": 3,
      "family_id": 1,
      "path_type": "branch",
      "branch_from": 1,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "RAA",
          "premises_used": [
            {
              "id": "Rule7",
              "prover9": "(-(A13 -> -A3) -> A15)",
              "prover9_expression": "(-(emergency_use_authorization(drug) -> -requires_clinical_trials(drug)) -> regulatory_investigation(drug))",
              "natural": "If the implication that emergency use authorization negates the need for clinical trials does not hold, then the drug faces regulatory investigation."
            },
            {
              "id": "Rule8",
              "prover9": "(-(A13 -> -A3) -> -A15)",
              "prover9_expression": "(-(emergency_use_authorization(drug) -> -requires_clinical_trials(drug)) -> -regulatory_investigation(drug))",
              "natural": "In the situation where emergency use authorization failing to waive clinical trials occurs, regulatory investigation does not follow."
            }
          ],
          "conclusion": "(A13 -> -A3)",
          "natural": "Under the condition that a drug has emergency use authorization, it does not require clinical trials."
        },
        {
          "step_number": 2,
          "rule_applied": "DE",
          "premises_used": [
            {
              "id": "Rule3",
              "prover9": "(A13 | A14)",
              "prover9_expression": "(emergency_use_authorization(drug) | conditional_approval(drug))",
              "natural": "A drug has emergency use authorization or it has conditional approval."
            },
            {
              "id": "Derived",
              "prover9": "(A13 -> -A3)",
              "prover9_expression": "(emergency_use_authorization(drug) -> -requires_clinical_trials(drug))",
              "natural": "Under the condition that a drug has emergency use authorization, it does not require clinical trials."
            },
            {
              "id": "Rule4",
              "prover9": "(A14 -> -A3)",
              "prover9_expression": "(conditional_approval(drug) -> -requires_clinical_trials(drug))",
              "natural": "If a drug has conditional approval, then it does not require clinical trials."
            }
          ],
          "conclusion": "-A3",
          "natural": "A drug does not require clinical trials."
        },
        {
          "step_number": 3,
          "rule_applied": "MT",
          "premises_used": [
            {
              "id": "Rule9",
              "prover9": "(-(A2 -> G) -> A3)",
              "prover9_expression": "(-(approved(substance, platform) -> market_available(product)) -> requires_clinical_trials(drug))",
              "natural": "Whenever the approval of substance for the platform does not lead to market availability, the drug requires clinical trials."
            },
            {
              "id": "Derived",
              "prover9": "-A3",
              "prover9_expression": "-requires_clinical_trials(drug)",
              "natural": "A drug does not require clinical trials."
            }
          ],
          "conclusion": "(A2 -> G)",
          "natural": "If substance is approved for the platform, then the product is market available."
        },
        {
          "step_number": 4,
          "rule_applied": "DE",
          "premises_used": [
            {
              "id": "Rule2",
              "prover9": "(A1 | A2)",
              "prover9_expression": "(approved(alcohol, platform) | approved(substance, platform))",
              "natural": "Either alcohol is approved for the platform or substance is approved for the platform."
            },
            {
              "id": "Rule1",
              "prover9": "(A1 -> G)",
              "prover9_expression": "(approved(alcohol, platform) -> market_available(product))",
              "natural": "Provided that alcohol is approved for the platform, then the product becomes market available."
            },
            {
              "id": "Derived",
              "prover9": "(A2 -> G)",
              "prover9_expression": "(approved(substance, platform) -> market_available(product))",
              "natural": "If substance is approved for the platform, then the product is market available."
            }
          ],
          "conclusion": "G",
          "natural": "A product is market available."
        }
      ]
    }
  ]
}